TNFRSF1B and neoplasm: Additionally, TNFR2 is expressed primarily on immune cells including Treg and MDSC (111, 120), where acute production of TNF-α is associated with Treg expansion and increased infiltration of Treg and MDSC populations in the TME, leading to tumor progression and decreased efficacy of immunotherapies (111, 121).